Business Description
Gritstone Bio Inc
NAICS : 325412
SIC : 2836
ISIN : US39868T1051
Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.54 | |||||
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 4.62 | |||||
| Debt-to-EBITDA | -0.85 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -9.75 | |||||
| Beneish M-Score | -3.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -49.3 | |||||
| 3-Year EBITDA Growth Rate | 25.1 | |||||
| 3-Year EPS without NRI Growth Rate | 24.5 | |||||
| 3-Year FCF Growth Rate | 23.6 | |||||
| 3-Year Book Growth Rate | -53.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.64 | |||||
| Future 3-5Y Total Revenue Growth Rate | 95.75 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.14 | |||||
| 9-Day RSI | 47.83 | |||||
| 14-Day RSI | 46.77 | |||||
| 6-1 Month Momentum % | -91.66 | |||||
| 12-1 Month Momentum % | -96.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.54 | |||||
| Quick Ratio | 2.54 | |||||
| Cash Ratio | 2.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -45.1 | |||||
| Shareholder Yield % | -4780.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -27512.9 | |||||
| Net Margin % | -26821.17 | |||||
| FCF Margin % | -22498.49 | |||||
| ROE % | -244.95 | |||||
| ROA % | -76.69 | |||||
| ROIC % | -128.77 | |||||
| ROC (Joel Greenblatt) % | -151.89 | |||||
| ROCE % | -86.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.17 | |||||
| PB Ratio | 0.08 | |||||
| Price-to-Tangible-Book | 0.08 | |||||
| EV-to-EBIT | -0.38 | |||||
| EV-to-EBITDA | -0.4 | |||||
| EV-to-Revenue | 98.25 | |||||
| EV-to-Forward-Revenue | 6.9 | |||||
| EV-to-FCF | -0.43 | |||||
| Earnings Yield (Greenblatt) % | -263.16 | |||||
| FCF Yield % | -6080.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gritstone Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.463 | ||
| EPS (TTM) (€) | -1.009 | ||
| Beta | 0.96 | ||
| Volatility % | 241.05 | ||
| 14-Day RSI | 46.77 | ||
| 14-Day ATR (€) | 0.013449 | ||
| 20-Day SMA (€) | 0.017835 | ||
| 12-1 Month Momentum % | -96.08 | ||
| 52-Week Range (€) | 0.0001 - 2.645 | ||
| Shares Outstanding (Mil) | 147.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gritstone Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gritstone Bio Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gritstone Bio Inc Frequently Asked Questions
What is Gritstone Bio Inc(FRA:2JQ)'s stock price today?
The current price of FRA:2JQ is €0.01. The 52 week high of FRA:2JQ is €2.65 and 52 week low is €0.00.
When is next earnings date of Gritstone Bio Inc(FRA:2JQ)?
The next earnings date of Gritstone Bio Inc(FRA:2JQ) is 2024-12-27 Est..
Does Gritstone Bio Inc(FRA:2JQ) pay dividends? If so, how much?
Gritstone Bio Inc(FRA:2JQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers